Skip to main content
Erschienen in: Child's Nervous System 9/2020

16.03.2020 | Original Article

Effects of propofol on hippocampal neuron viability

verfasst von: Xiaodong Xu, Guohua Wu, Yong Liu, Liangcheng Zhang

Erschienen in: Child's Nervous System | Ausgabe 9/2020

Einloggen, um Zugang zu erhalten

Abstract

Purpose

In this study, we investigated the effects of different concentration of propofol on cell viability of hippocampal neurons and explored the possible mechanism.

Patients and methods

Primary hippocampal neurons were cultured in vitro and treated with different concentration of propofol. MTT was used to examine the survival of neurons. Flow cytometry was used to detect the neuronal apoptosis. Western-blot analysis was used to examine the expression level of p-p38MAPK and p38MAPK.

Results

We found that low concentration propofol (0.5 μM and 1 μM) promoted the cell survival rate; however, high concentration of propofol (10 μM,50 μM,100 μM,150 μM, and 200 μM) decreased the cell survival rate (P < 0.05). Flow cytometry showed that the neuronal apoptosis rate was decreased in 1 μM propofol group (P < 0.05), but was significantly higher in10μM, 100 μM and 200 μM groups in a concentration-dependent manner (P < 0.05 or P < 0.01). Western blot revealed that the propofol induced the phosphorylation of p38MAPK concentration-dependently and time-dependently. SB203580, one inhibitor of p38MAPK, increased the cell survival rate and decreased the cell apoptosis induced by high concentration of propofol.

Conclusion

Low concentration of propofol improved the survival rate of neurons, while high concentration of propofol promoted the cell apoptosis and decreased the cell viability. p38MAPK pathway is involved the effect of high concentration of propofol promoted on primary hippocampal neurons viability and apoptosis.
Literatur
1.
Zurück zum Zitat Olney JW (2002) New insights and new issues in developmental neurotoxicology. Neurotoxicology 23:659–668CrossRef Olney JW (2002) New insights and new issues in developmental neurotoxicology. Neurotoxicology 23:659–668CrossRef
2.
Zurück zum Zitat Sprung J, Flick RP, Katusic SK, Colligan RC, Barbaresi WJ, Bojanic K, Welch TL, Olson MD, Hanson AC, Schroeder DR, Wilder RT, Warner DO (2012) Attention-deficit/hyperactivity disorder after early exposure to procedures requiring general anesthesia Mayo Clinic proceedings 87:120–129 Sprung J, Flick RP, Katusic SK, Colligan RC, Barbaresi WJ, Bojanic K, Welch TL, Olson MD, Hanson AC, Schroeder DR, Wilder RT, Warner DO (2012) Attention-deficit/hyperactivity disorder after early exposure to procedures requiring general anesthesia Mayo Clinic proceedings 87:120–129
3.
Zurück zum Zitat Flick RP, Katusic SK, Colligan RC, Wilder RT, Voigt RG, Olson MD, Sprung J, Weaver AL, Schroeder DR, Warner DO (2011) Cognitive and behavioral outcomes after early exposure to anesthesia and surgery. Pediatrics 128:e1053–e1061CrossRef Flick RP, Katusic SK, Colligan RC, Wilder RT, Voigt RG, Olson MD, Sprung J, Weaver AL, Schroeder DR, Warner DO (2011) Cognitive and behavioral outcomes after early exposure to anesthesia and surgery. Pediatrics 128:e1053–e1061CrossRef
4.
Zurück zum Zitat Loepke AW, Soriano SG (2008) An assessment of the effects of general anesthetics on developing brain structure and neurocognitive function. Anesth Analg 106:1681–1707CrossRef Loepke AW, Soriano SG (2008) An assessment of the effects of general anesthetics on developing brain structure and neurocognitive function. Anesth Analg 106:1681–1707CrossRef
5.
Zurück zum Zitat Brenner L, Kettner SC, Marhofer P, Latzke D, Willschke H, Kimberger O, Adelmann D, Machata AM (2010) Caudal anaesthesia under sedation: a prospective analysis of 512 infants and children. Br J Anaesth 104:751–755CrossRef Brenner L, Kettner SC, Marhofer P, Latzke D, Willschke H, Kimberger O, Adelmann D, Machata AM (2010) Caudal anaesthesia under sedation: a prospective analysis of 512 infants and children. Br J Anaesth 104:751–755CrossRef
6.
Zurück zum Zitat Istaphanous GK, Loepke AW (2009) General anesthetics and the developing brain. Curr Opin Anaesthesiol 22:368–373CrossRef Istaphanous GK, Loepke AW (2009) General anesthetics and the developing brain. Curr Opin Anaesthesiol 22:368–373CrossRef
7.
Zurück zum Zitat Karmarkar SW, Bottum KM, Tischkau SA (2010) Considerations for the use of anesthetics in neurotoxicity studies. Comp Med 60:256–262PubMedPubMedCentral Karmarkar SW, Bottum KM, Tischkau SA (2010) Considerations for the use of anesthetics in neurotoxicity studies. Comp Med 60:256–262PubMedPubMedCentral
8.
Zurück zum Zitat Fredriksson A, Ponten E, Gordh T, Eriksson P (2007) Neonatal exposure to a combination of N-methyl-D-aspartate and gamma-aminobutyric acid type A receptor anesthetic agents potentiates apoptotic neurodegeneration and persistent behavioral deficits. Anesthesiology 107:427–436CrossRef Fredriksson A, Ponten E, Gordh T, Eriksson P (2007) Neonatal exposure to a combination of N-methyl-D-aspartate and gamma-aminobutyric acid type A receptor anesthetic agents potentiates apoptotic neurodegeneration and persistent behavioral deficits. Anesthesiology 107:427–436CrossRef
9.
Zurück zum Zitat Fibuch EE, Wang JQ (2007) Inhibition of the MAPK/ERK cascade: a potential transcription-dependent mechanism for the amnesic effect of anesthetic propofol. Neurosci Bull 23:119–124CrossRef Fibuch EE, Wang JQ (2007) Inhibition of the MAPK/ERK cascade: a potential transcription-dependent mechanism for the amnesic effect of anesthetic propofol. Neurosci Bull 23:119–124CrossRef
10.
Zurück zum Zitat Bercker S, Bert B, Bittigau P, Felderhoff-Muser U, Buhrer C, Ikonomidou C, Weise M, Kaisers UX, Kerner T (2009) Neurodegeneration in newborn rats following propofol and sevoflurane anesthesia. Neurotox Res 16:140–147CrossRef Bercker S, Bert B, Bittigau P, Felderhoff-Muser U, Buhrer C, Ikonomidou C, Weise M, Kaisers UX, Kerner T (2009) Neurodegeneration in newborn rats following propofol and sevoflurane anesthesia. Neurotox Res 16:140–147CrossRef
11.
Zurück zum Zitat Schifilliti D, Grasso G, Conti A, Fodale V (2010) Anaesthetic-related neuroprotection: intravenous or inhalational agents? CNS drugs 24:893–907PubMed Schifilliti D, Grasso G, Conti A, Fodale V (2010) Anaesthetic-related neuroprotection: intravenous or inhalational agents? CNS drugs 24:893–907PubMed
12.
Zurück zum Zitat Fath T, Ke YD, Gunning P, Gotz J, Ittner LM (2009) Primary support cultures of hippocampal and substantia nigra neurons. Nat Protoc 4:78–85CrossRef Fath T, Ke YD, Gunning P, Gotz J, Ittner LM (2009) Primary support cultures of hippocampal and substantia nigra neurons. Nat Protoc 4:78–85CrossRef
13.
Zurück zum Zitat Li Z, Liu P, Zhang H, Zhao S, Jin Z, Li R, Guo Y, Wang X (2017) Role of GABAB receptors and p38MAPK/NF-kappaB pathway in paclitaxel-induced apoptosis of hippocampal neurons. Pharm Biol 55:2188–2195CrossRef Li Z, Liu P, Zhang H, Zhao S, Jin Z, Li R, Guo Y, Wang X (2017) Role of GABAB receptors and p38MAPK/NF-kappaB pathway in paclitaxel-induced apoptosis of hippocampal neurons. Pharm Biol 55:2188–2195CrossRef
14.
Zurück zum Zitat Wei M, Zhang K, Li Z, Yang P, Zhang J, Liu H (2017) Pyruvate attenuates the injury of PC12 cells induced by hypoxia via inhibiting p38MAPK phosphorylation. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 33:1191–1195PubMed Wei M, Zhang K, Li Z, Yang P, Zhang J, Liu H (2017) Pyruvate attenuates the injury of PC12 cells induced by hypoxia via inhibiting p38MAPK phosphorylation. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 33:1191–1195PubMed
15.
Zurück zum Zitat Adembri C, Venturi L, Tani A, Chiarugi A, Gramigni E, Cozzi A, Pancani T, De Gaudio RA, Pellegrini-Giampietro DE (2006) Neuroprotective effects of propofol in models of cerebral ischemia: inhibition of mitochondrial swelling as a possible mechanism. Anesthesiology 104:80–89CrossRef Adembri C, Venturi L, Tani A, Chiarugi A, Gramigni E, Cozzi A, Pancani T, De Gaudio RA, Pellegrini-Giampietro DE (2006) Neuroprotective effects of propofol in models of cerebral ischemia: inhibition of mitochondrial swelling as a possible mechanism. Anesthesiology 104:80–89CrossRef
16.
Zurück zum Zitat Adembri C, Venturi L, Pellegrini-Giampietro DE (2007) Neuroprotective effects of propofol in acute cerebral injury. CNS Drug Rev 13:333–351CrossRef Adembri C, Venturi L, Pellegrini-Giampietro DE (2007) Neuroprotective effects of propofol in acute cerebral injury. CNS Drug Rev 13:333–351CrossRef
17.
Zurück zum Zitat Ferreira DA, Nunes CS, Antunes L, Lobo F, Amorim P (2006) Practical aspects of the use of target controlled infusion with remifentanil in neurosurgical patients: predicted cerebral concentrations at intubation, incision and extubation. Acta Anaesthesiol Belg 57:265–270PubMed Ferreira DA, Nunes CS, Antunes L, Lobo F, Amorim P (2006) Practical aspects of the use of target controlled infusion with remifentanil in neurosurgical patients: predicted cerebral concentrations at intubation, incision and extubation. Acta Anaesthesiol Belg 57:265–270PubMed
18.
Zurück zum Zitat Sall JW, Stratmann G, Leong J, Woodward E, Bickler PE (2012) Propofol at clinically relevant concentrations increases neuronal differentiation but is not toxic to hippocampal neural precursor cells in vitro. Anesthesiology 117:1080–1090CrossRef Sall JW, Stratmann G, Leong J, Woodward E, Bickler PE (2012) Propofol at clinically relevant concentrations increases neuronal differentiation but is not toxic to hippocampal neural precursor cells in vitro. Anesthesiology 117:1080–1090CrossRef
19.
Zurück zum Zitat Hudson AE, Hemmings HC Jr (2011) Are anaesthetics toxic to the brain? Br J Anaesth 107:30–37CrossRef Hudson AE, Hemmings HC Jr (2011) Are anaesthetics toxic to the brain? Br J Anaesth 107:30–37CrossRef
20.
Zurück zum Zitat Vutskits L, Gascon E, Tassonyi E, Kiss JZ (2005) Clinically relevant concentrations of propofol but not midazolam alter in vitro dendritic development of isolated gamma-aminobutyric acid-positive interneurons. Anesthesiology 102:970–976CrossRef Vutskits L, Gascon E, Tassonyi E, Kiss JZ (2005) Clinically relevant concentrations of propofol but not midazolam alter in vitro dendritic development of isolated gamma-aminobutyric acid-positive interneurons. Anesthesiology 102:970–976CrossRef
21.
Zurück zum Zitat Wu GJ, Chen WF, Hung HC, Jean YH, Sung CS, Chakraborty C, Lee HP, Chen NF, Wen ZH (2011) Effects of propofol on proliferation and anti-apoptosis of neuroblastoma SH-SY5Y cell line: new insights into neuroprotection. Brain Res 1384:42–50CrossRef Wu GJ, Chen WF, Hung HC, Jean YH, Sung CS, Chakraborty C, Lee HP, Chen NF, Wen ZH (2011) Effects of propofol on proliferation and anti-apoptosis of neuroblastoma SH-SY5Y cell line: new insights into neuroprotection. Brain Res 1384:42–50CrossRef
22.
Zurück zum Zitat Harding SJ, Browne GJ, Miller BW, Prigent SA, Dickens M (2010) Activation of ASK1, downstream MAPKK and MAPK isoforms during cardiac ischaemia. Biochim Biophys Acta 1802:733–740CrossRef Harding SJ, Browne GJ, Miller BW, Prigent SA, Dickens M (2010) Activation of ASK1, downstream MAPKK and MAPK isoforms during cardiac ischaemia. Biochim Biophys Acta 1802:733–740CrossRef
23.
Zurück zum Zitat Savage MJ, Lin YG, Ciallella JR, Flood DG, Scott RW (2002) Activation of c-Jun N-terminal kinase and p38 in an Alzheimer's disease model is associated with amyloid deposition. J Neurosci 22:3376–3385CrossRef Savage MJ, Lin YG, Ciallella JR, Flood DG, Scott RW (2002) Activation of c-Jun N-terminal kinase and p38 in an Alzheimer's disease model is associated with amyloid deposition. J Neurosci 22:3376–3385CrossRef
24.
Zurück zum Zitat Riewpaiboon A, Nuchprayoon I, Torcharus K, Indaratna K, Thavorncharoensap M, Ubol BO (2010) Economic burden of beta-thalassemia/Hb E and beta-thalassemia major in Thai children BMC research notes 3:29 Riewpaiboon A, Nuchprayoon I, Torcharus K, Indaratna K, Thavorncharoensap M, Ubol BO (2010) Economic burden of beta-thalassemia/Hb E and beta-thalassemia major in Thai children BMC research notes 3:29
25.
Zurück zum Zitat Wu XJ, Zheng YJ, Cui YY, Zhu L, Lu Y, Chen HZ (2007) Propofol attenuates oxidative stress-induced PC12 cell injury via p38 MAP kinase dependent pathway. Acta Pharmacol Sin 28:1123–1128CrossRef Wu XJ, Zheng YJ, Cui YY, Zhu L, Lu Y, Chen HZ (2007) Propofol attenuates oxidative stress-induced PC12 cell injury via p38 MAP kinase dependent pathway. Acta Pharmacol Sin 28:1123–1128CrossRef
26.
Zurück zum Zitat Wei L, Matsumoto H, Yamaguchi H (2013) Propofol attenuates lipopolysaccharide-induced monocyte chemoattractant protein-1 production through p38 MAPK and SAPK/JNK in alveolar epithelial cells. J Anesth 27:366–373CrossRef Wei L, Matsumoto H, Yamaguchi H (2013) Propofol attenuates lipopolysaccharide-induced monocyte chemoattractant protein-1 production through p38 MAPK and SAPK/JNK in alveolar epithelial cells. J Anesth 27:366–373CrossRef
27.
Zurück zum Zitat Tang J, Chen X, Tu W, Guo Y, Zhao Z, Xue Q, Lin C, Xiao J, Sun X, Tao T, Gu M, Liu Y (2011) Propofol inhibits the activation of p38 through up-regulating the expression of annexin A1 to exert its anti-inflammation effect. PLoS One 6:e27890CrossRef Tang J, Chen X, Tu W, Guo Y, Zhao Z, Xue Q, Lin C, Xiao J, Sun X, Tao T, Gu M, Liu Y (2011) Propofol inhibits the activation of p38 through up-regulating the expression of annexin A1 to exert its anti-inflammation effect. PLoS One 6:e27890CrossRef
28.
Zurück zum Zitat Wu KC, Yang ST, Hsia TC, Yang JS, Chiou SM, Lu CC, Wu RS, Chung JG (2012) Suppression of cell invasion and migration by propofol are involved in down-regulating matrix metalloproteinase-2 and p38 MAPK signaling in A549 human lung adenocarcinoma epithelial cells. Anticancer Res 32:4833–4842PubMed Wu KC, Yang ST, Hsia TC, Yang JS, Chiou SM, Lu CC, Wu RS, Chung JG (2012) Suppression of cell invasion and migration by propofol are involved in down-regulating matrix metalloproteinase-2 and p38 MAPK signaling in A549 human lung adenocarcinoma epithelial cells. Anticancer Res 32:4833–4842PubMed
Metadaten
Titel
Effects of propofol on hippocampal neuron viability
verfasst von
Xiaodong Xu
Guohua Wu
Yong Liu
Liangcheng Zhang
Publikationsdatum
16.03.2020
Verlag
Springer Berlin Heidelberg
Erschienen in
Child's Nervous System / Ausgabe 9/2020
Print ISSN: 0256-7040
Elektronische ISSN: 1433-0350
DOI
https://doi.org/10.1007/s00381-020-04548-z

Weitere Artikel der Ausgabe 9/2020

Child's Nervous System 9/2020 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.